SlideShare a Scribd company logo
Part 1 – Preparing for the FDA Visit
• You asked for it… Wanted more review of the
steps involved

• This series is designed in parts
•
•
•
•
•

Part 1 – Preparing for the FDA
Part 2 – What to do when the FDA arrives
Part 3 – What to do while the FDA is there
Part 4 – What to do during closeout
Part 5 – What to do with the 483

This is Part 1 – Preparing for the FDA
People always ask me – “Troy, what is the best way to deal with
FDA issues?” I usually say…”Don’t have any”
That being said…there are things you can do to mitigate the
potential for you and your firm to have any serious FDA
problems.
Let’s start with the obvious:
• Did you have previous 483’s or Warning Letters? If so, did you
do everything to which you committed in the response? If
not, did you inform the FDA of the delay. During the audit is
not the time to find out you have issues…
• Will the next audit be – general GMP? For cause? PAI?
• If the inspection is going to be focused – you can focus your
attention to getting those things ready. Don’t forget – you
could always have a general inspection even during a PAI.
Your facility should always be ready for an inspection! But…it is
always a good idea to go through the facility to see how things look.
• Working in the factory every day can “dull” your senses to
problems that might have slowly developed over time
• Have someone “new” go through the facility
• Develop a “tour” plan for the areas – who will lead the tour in
different areas? What pathway to take (just remember – the FDA
can always go where they want – within reason)?
• Any signs of leaks in the ceiling? Cracked walls? Pealing Paint?
• All signage in place?
• Facility registration up to date?
• How does the exterior of the facility appear?
• Remediate anything possible!!
• Key is that everything should look organized and in CONTROL!
Look at how you are making the product(s) – specifically on the high
risk processes. If you have a PAI, focus on the product in the filing.
Are you in CONTROL?
How do you know?
Does the process match what you have filed?
Do the SOP’s conflict with the process?
Is your APR (annual product review) process up to date?

Have you maintained a good change control system?
Are people trained?
How do you control training – updates to SOPs?
Annual GMP training performed?
How do batch record errors look? Lots of errors or fairly clean?
Do the investigations often site “people” as the issue? If so,
then you have an issue.
Who are the folks that you will use as SME’s?
You need to check a lot of other items in preparation for the audit.
You know your system – check those areas that have potential for the
largest impact.
•
•
•
•
•
•

Warehouse practices
Customer complaints
Validation – equipment, process, cleaning, utilities, etc.
Lab operations
Calibration
Pest and rodent control

The key? Show you are in CONTROL!! How do you know it?
Call us at 513-860-3512
See our website at
www.Compliance-Insight.com
Send us an email at
info@Compliance-Insight.com

Thanks for watching!

More Related Content

Similar to FDA audit series part 1, Preparing for the Audit

REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
Michael Swit
 
Preparing for fda inspection safety review cdp
Preparing for fda inspection safety review cdpPreparing for fda inspection safety review cdp
Preparing for fda inspection safety review cdpCarmita Depasquale
 
Problem solving
Problem solvingProblem solving
Problem solving
Rob Graham
 
Root Cause Analysis: Think Again! - by Kevin Stewart
Root Cause Analysis: Think Again! - by Kevin StewartRoot Cause Analysis: Think Again! - by Kevin Stewart
Root Cause Analysis: Think Again! - by Kevin StewartASQ Reliability Division
 
Drug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory EnvironmentDrug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory Environment
Michael Swit
 
Shop floor 5's
Shop floor 5'sShop floor 5's
Shop floor 5'sKalacco
 
Bowker - Quality Systems Assessment – Garment Manufacturers.ppt
Bowker - Quality Systems Assessment – Garment Manufacturers.pptBowker - Quality Systems Assessment – Garment Manufacturers.ppt
Bowker - Quality Systems Assessment – Garment Manufacturers.ppt
amit mishra
 
The FDA just called, Now What?
The FDA just called, Now What?The FDA just called, Now What?
The FDA just called, Now What?
MasterControl
 
295910 633971289061398750
295910 633971289061398750295910 633971289061398750
295910 633971289061398750mefaiqahmed
 
5 S Basic Training
5 S Basic Training5 S Basic Training
5 S Basic Training
Ali Asghar Dossa
 
BASIC OF TRAINING
BASIC OF TRAININGBASIC OF TRAINING
BASIC OF TRAINING
Brahmas Pandey
 
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
Michael Swit
 
8D Training Presentation (tai lieu tham khao)
8D Training Presentation (tai lieu tham khao)8D Training Presentation (tai lieu tham khao)
8D Training Presentation (tai lieu tham khao)
nguyenanvuong2007
 
LEAN: 5 Keys to Success
LEAN: 5 Keys to SuccessLEAN: 5 Keys to Success
5 why training_presentation
5 why training_presentation5 why training_presentation
5 why training_presentation
Md.Aminul Islam ,CMRP,CSSBB
 
5s System
5s System5s System
5s System
Mohammed Imran
 

Similar to FDA audit series part 1, Preparing for the Audit (20)

REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
 
Kaizen
KaizenKaizen
Kaizen
 
Preparing for fda inspection safety review cdp
Preparing for fda inspection safety review cdpPreparing for fda inspection safety review cdp
Preparing for fda inspection safety review cdp
 
Problem solving
Problem solvingProblem solving
Problem solving
 
Root Cause Analysis: Think Again! - by Kevin Stewart
Root Cause Analysis: Think Again! - by Kevin StewartRoot Cause Analysis: Think Again! - by Kevin Stewart
Root Cause Analysis: Think Again! - by Kevin Stewart
 
Drug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory EnvironmentDrug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory Environment
 
Shop floor 5's
Shop floor 5'sShop floor 5's
Shop floor 5's
 
Bowker - Quality Systems Assessment – Garment Manufacturers.ppt
Bowker - Quality Systems Assessment – Garment Manufacturers.pptBowker - Quality Systems Assessment – Garment Manufacturers.ppt
Bowker - Quality Systems Assessment – Garment Manufacturers.ppt
 
The FDA just called, Now What?
The FDA just called, Now What?The FDA just called, Now What?
The FDA just called, Now What?
 
295910 633971289061398750
295910 633971289061398750295910 633971289061398750
295910 633971289061398750
 
Pai
PaiPai
Pai
 
5 S Basic Training
5 S Basic Training5 S Basic Training
5 S Basic Training
 
BASIC OF TRAINING
BASIC OF TRAININGBASIC OF TRAINING
BASIC OF TRAINING
 
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
 
8D Training Presentation (tai lieu tham khao)
8D Training Presentation (tai lieu tham khao)8D Training Presentation (tai lieu tham khao)
8D Training Presentation (tai lieu tham khao)
 
LEAN: 5 Keys to Success
LEAN: 5 Keys to SuccessLEAN: 5 Keys to Success
LEAN: 5 Keys to Success
 
5 why training_presentation
5 why training_presentation5 why training_presentation
5 why training_presentation
 
5s
5s5s
5s
 
5s System
5s System5s System
5s System
 
5s ppt
5s ppt5s ppt
5s ppt
 

More from Compliance Insight, Inc.

GCP Overview by Compliance Insight, Inc.
GCP Overview by Compliance Insight, Inc.GCP Overview by Compliance Insight, Inc.
GCP Overview by Compliance Insight, Inc.
Compliance Insight, Inc.
 
About Compliance Insight Inc.
About Compliance Insight Inc.About Compliance Insight Inc.
About Compliance Insight Inc.
Compliance Insight, Inc.
 
FDA 483 observations in the lab
FDA 483 observations in the labFDA 483 observations in the lab
FDA 483 observations in the lab
Compliance Insight, Inc.
 
Basics of FDA GMP Training
Basics of FDA GMP TrainingBasics of FDA GMP Training
Basics of FDA GMP Training
Compliance Insight, Inc.
 
FDA Audit - The Do and Don't List
FDA Audit - The Do and Don't ListFDA Audit - The Do and Don't List
FDA Audit - The Do and Don't List
Compliance Insight, Inc.
 
FDA GMP Training - The Quality Audit
FDA GMP Training - The Quality AuditFDA GMP Training - The Quality Audit
FDA GMP Training - The Quality Audit
Compliance Insight, Inc.
 
Top 22 Tips: Writing For FDA Compliance
Top 22 Tips: Writing For FDA ComplianceTop 22 Tips: Writing For FDA Compliance
Top 22 Tips: Writing For FDA Compliance
Compliance Insight, Inc.
 
21 cfr, parts 210 211
21 cfr, parts 210 21121 cfr, parts 210 211
21 cfr, parts 210 211
Compliance Insight, Inc.
 
FDA Warning Letter
FDA Warning LetterFDA Warning Letter
FDA Warning Letter
Compliance Insight, Inc.
 
FDA 483
FDA 483FDA 483
Fda Inspection
Fda InspectionFda Inspection
Fda Inspection
Compliance Insight, Inc.
 

More from Compliance Insight, Inc. (12)

July 2015
July 2015July 2015
July 2015
 
GCP Overview by Compliance Insight, Inc.
GCP Overview by Compliance Insight, Inc.GCP Overview by Compliance Insight, Inc.
GCP Overview by Compliance Insight, Inc.
 
About Compliance Insight Inc.
About Compliance Insight Inc.About Compliance Insight Inc.
About Compliance Insight Inc.
 
FDA 483 observations in the lab
FDA 483 observations in the labFDA 483 observations in the lab
FDA 483 observations in the lab
 
Basics of FDA GMP Training
Basics of FDA GMP TrainingBasics of FDA GMP Training
Basics of FDA GMP Training
 
FDA Audit - The Do and Don't List
FDA Audit - The Do and Don't ListFDA Audit - The Do and Don't List
FDA Audit - The Do and Don't List
 
FDA GMP Training - The Quality Audit
FDA GMP Training - The Quality AuditFDA GMP Training - The Quality Audit
FDA GMP Training - The Quality Audit
 
Top 22 Tips: Writing For FDA Compliance
Top 22 Tips: Writing For FDA ComplianceTop 22 Tips: Writing For FDA Compliance
Top 22 Tips: Writing For FDA Compliance
 
21 cfr, parts 210 211
21 cfr, parts 210 21121 cfr, parts 210 211
21 cfr, parts 210 211
 
FDA Warning Letter
FDA Warning LetterFDA Warning Letter
FDA Warning Letter
 
FDA 483
FDA 483FDA 483
FDA 483
 
Fda Inspection
Fda InspectionFda Inspection
Fda Inspection
 

Recently uploaded

Company Valuation webinar series - Tuesday, 4 June 2024
Company Valuation webinar series - Tuesday, 4 June 2024Company Valuation webinar series - Tuesday, 4 June 2024
Company Valuation webinar series - Tuesday, 4 June 2024
FelixPerez547899
 
The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...
Adam Smith
 
amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05
marketing317746
 
Understanding User Needs and Satisfying Them
Understanding User Needs and Satisfying ThemUnderstanding User Needs and Satisfying Them
Understanding User Needs and Satisfying Them
Aggregage
 
Digital Transformation and IT Strategy Toolkit and Templates
Digital Transformation and IT Strategy Toolkit and TemplatesDigital Transformation and IT Strategy Toolkit and Templates
Digital Transformation and IT Strategy Toolkit and Templates
Aurelien Domont, MBA
 
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Lviv Startup Club
 
The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...
Adam Smith
 
An introduction to the cryptocurrency investment platform Binance Savings.
An introduction to the cryptocurrency investment platform Binance Savings.An introduction to the cryptocurrency investment platform Binance Savings.
An introduction to the cryptocurrency investment platform Binance Savings.
Any kyc Account
 
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s Dholera
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s DholeraTata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s Dholera
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s Dholera
Avirahi City Dholera
 
Discover the innovative and creative projects that highlight my journey throu...
Discover the innovative and creative projects that highlight my journey throu...Discover the innovative and creative projects that highlight my journey throu...
Discover the innovative and creative projects that highlight my journey throu...
dylandmeas
 
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
AnnySerafinaLove
 
FIA officials brutally tortured innocent and snatched 200 Bitcoins of worth 4...
FIA officials brutally tortured innocent and snatched 200 Bitcoins of worth 4...FIA officials brutally tortured innocent and snatched 200 Bitcoins of worth 4...
FIA officials brutally tortured innocent and snatched 200 Bitcoins of worth 4...
jamalseoexpert1978
 
Building Your Employer Brand with Social Media
Building Your Employer Brand with Social MediaBuilding Your Employer Brand with Social Media
Building Your Employer Brand with Social Media
LuanWise
 
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesEvent Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Holger Mueller
 
Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership Agile Tour Geneve 2024Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership Agile Tour Geneve 2024
Kirill Klimov
 
Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)
Lviv Startup Club
 
LA HUG - Video Testimonials with Chynna Morgan - June 2024
LA HUG - Video Testimonials with Chynna Morgan - June 2024LA HUG - Video Testimonials with Chynna Morgan - June 2024
LA HUG - Video Testimonials with Chynna Morgan - June 2024
Lital Barkan
 
Exploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social DreamingExploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social Dreaming
Nicola Wreford-Howard
 
Authentically Social Presented by Corey Perlman
Authentically Social Presented by Corey PerlmanAuthentically Social Presented by Corey Perlman
Authentically Social Presented by Corey Perlman
Corey Perlman, Social Media Speaker and Consultant
 
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdfikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
agatadrynko
 

Recently uploaded (20)

Company Valuation webinar series - Tuesday, 4 June 2024
Company Valuation webinar series - Tuesday, 4 June 2024Company Valuation webinar series - Tuesday, 4 June 2024
Company Valuation webinar series - Tuesday, 4 June 2024
 
The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...
 
amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05
 
Understanding User Needs and Satisfying Them
Understanding User Needs and Satisfying ThemUnderstanding User Needs and Satisfying Them
Understanding User Needs and Satisfying Them
 
Digital Transformation and IT Strategy Toolkit and Templates
Digital Transformation and IT Strategy Toolkit and TemplatesDigital Transformation and IT Strategy Toolkit and Templates
Digital Transformation and IT Strategy Toolkit and Templates
 
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
Evgen Osmak: Methods of key project parameters estimation: from the shaman-in...
 
The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...The Influence of Marketing Strategy and Market Competition on Business Perfor...
The Influence of Marketing Strategy and Market Competition on Business Perfor...
 
An introduction to the cryptocurrency investment platform Binance Savings.
An introduction to the cryptocurrency investment platform Binance Savings.An introduction to the cryptocurrency investment platform Binance Savings.
An introduction to the cryptocurrency investment platform Binance Savings.
 
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s Dholera
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s DholeraTata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s Dholera
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s Dholera
 
Discover the innovative and creative projects that highlight my journey throu...
Discover the innovative and creative projects that highlight my journey throu...Discover the innovative and creative projects that highlight my journey throu...
Discover the innovative and creative projects that highlight my journey throu...
 
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
 
FIA officials brutally tortured innocent and snatched 200 Bitcoins of worth 4...
FIA officials brutally tortured innocent and snatched 200 Bitcoins of worth 4...FIA officials brutally tortured innocent and snatched 200 Bitcoins of worth 4...
FIA officials brutally tortured innocent and snatched 200 Bitcoins of worth 4...
 
Building Your Employer Brand with Social Media
Building Your Employer Brand with Social MediaBuilding Your Employer Brand with Social Media
Building Your Employer Brand with Social Media
 
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesEvent Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
 
Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership Agile Tour Geneve 2024Organizational Change Leadership Agile Tour Geneve 2024
Organizational Change Leadership Agile Tour Geneve 2024
 
Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)
 
LA HUG - Video Testimonials with Chynna Morgan - June 2024
LA HUG - Video Testimonials with Chynna Morgan - June 2024LA HUG - Video Testimonials with Chynna Morgan - June 2024
LA HUG - Video Testimonials with Chynna Morgan - June 2024
 
Exploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social DreamingExploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social Dreaming
 
Authentically Social Presented by Corey Perlman
Authentically Social Presented by Corey PerlmanAuthentically Social Presented by Corey Perlman
Authentically Social Presented by Corey Perlman
 
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdfikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
 

FDA audit series part 1, Preparing for the Audit

  • 1. Part 1 – Preparing for the FDA Visit
  • 2. • You asked for it… Wanted more review of the steps involved • This series is designed in parts • • • • • Part 1 – Preparing for the FDA Part 2 – What to do when the FDA arrives Part 3 – What to do while the FDA is there Part 4 – What to do during closeout Part 5 – What to do with the 483 This is Part 1 – Preparing for the FDA
  • 3. People always ask me – “Troy, what is the best way to deal with FDA issues?” I usually say…”Don’t have any” That being said…there are things you can do to mitigate the potential for you and your firm to have any serious FDA problems. Let’s start with the obvious: • Did you have previous 483’s or Warning Letters? If so, did you do everything to which you committed in the response? If not, did you inform the FDA of the delay. During the audit is not the time to find out you have issues… • Will the next audit be – general GMP? For cause? PAI? • If the inspection is going to be focused – you can focus your attention to getting those things ready. Don’t forget – you could always have a general inspection even during a PAI.
  • 4. Your facility should always be ready for an inspection! But…it is always a good idea to go through the facility to see how things look. • Working in the factory every day can “dull” your senses to problems that might have slowly developed over time • Have someone “new” go through the facility • Develop a “tour” plan for the areas – who will lead the tour in different areas? What pathway to take (just remember – the FDA can always go where they want – within reason)? • Any signs of leaks in the ceiling? Cracked walls? Pealing Paint? • All signage in place? • Facility registration up to date? • How does the exterior of the facility appear? • Remediate anything possible!! • Key is that everything should look organized and in CONTROL!
  • 5. Look at how you are making the product(s) – specifically on the high risk processes. If you have a PAI, focus on the product in the filing. Are you in CONTROL? How do you know? Does the process match what you have filed? Do the SOP’s conflict with the process? Is your APR (annual product review) process up to date? Have you maintained a good change control system?
  • 6. Are people trained? How do you control training – updates to SOPs? Annual GMP training performed? How do batch record errors look? Lots of errors or fairly clean? Do the investigations often site “people” as the issue? If so, then you have an issue. Who are the folks that you will use as SME’s?
  • 7. You need to check a lot of other items in preparation for the audit. You know your system – check those areas that have potential for the largest impact. • • • • • • Warehouse practices Customer complaints Validation – equipment, process, cleaning, utilities, etc. Lab operations Calibration Pest and rodent control The key? Show you are in CONTROL!! How do you know it?
  • 8. Call us at 513-860-3512 See our website at www.Compliance-Insight.com Send us an email at info@Compliance-Insight.com Thanks for watching!